QI
DGX icon

Quotient Investors’s Quest Diagnostics DGX Stock Holding History

Quotient Investors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-49,164
Closed -$3.56M – 230
2015
Q2 		$3.56M Buy
+49,164
New +$3.63M 0.49% 58

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Quotient Investors's DGX Position: Q3 2015 in Review

Quotient Investors sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 49,164 shares — an estimated $3.56M sold.

Quotient Investors first reported a position in DGX in Q2 2015 and held it in 1 quarter. The position peaked at $3.56M in Q2 2015. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

  • Quotient Investors reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
  • Quotient Investors sold 49,164 Quest Diagnostics shares in Q3 2015, an estimated $3.56M.
  • Quotient Investors first reported a position in Quest Diagnostics in Q2 2015 and held it in 1 quarter.
  • Quotient Investors's Quest Diagnostics position peaked at $3.56M in Q2 2015.
  • 540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Quotient Investors's 13F filing for Q3 2015, filed 21 Oct 2015.